Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP597813.RArze4YsEX_NYlxE_x34g_P77KmyxKdG_u9GGoAtdXsB0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP597813.RArze4YsEX_NYlxE_x34g_P77KmyxKdG_u9GGoAtdXsB0130_assertion type Assertion NP597813.RArze4YsEX_NYlxE_x34g_P77KmyxKdG_u9GGoAtdXsB0130_head.
- NP597813.RArze4YsEX_NYlxE_x34g_P77KmyxKdG_u9GGoAtdXsB0130_assertion description "[We defined clinically relevant time points for NPM1(mut) MRD assessment that allow for the identification of patients with AML who are at high risk of relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP597813.RArze4YsEX_NYlxE_x34g_P77KmyxKdG_u9GGoAtdXsB0130_provenance.
- NP597813.RArze4YsEX_NYlxE_x34g_P77KmyxKdG_u9GGoAtdXsB0130_assertion evidence source_evidence_literature NP597813.RArze4YsEX_NYlxE_x34g_P77KmyxKdG_u9GGoAtdXsB0130_provenance.
- NP597813.RArze4YsEX_NYlxE_x34g_P77KmyxKdG_u9GGoAtdXsB0130_assertion SIO_000772 21555683 NP597813.RArze4YsEX_NYlxE_x34g_P77KmyxKdG_u9GGoAtdXsB0130_provenance.
- NP597813.RArze4YsEX_NYlxE_x34g_P77KmyxKdG_u9GGoAtdXsB0130_assertion wasDerivedFrom befree-20150227 NP597813.RArze4YsEX_NYlxE_x34g_P77KmyxKdG_u9GGoAtdXsB0130_provenance.
- NP597813.RArze4YsEX_NYlxE_x34g_P77KmyxKdG_u9GGoAtdXsB0130_assertion wasGeneratedBy ECO_0000203 NP597813.RArze4YsEX_NYlxE_x34g_P77KmyxKdG_u9GGoAtdXsB0130_provenance.